Saturday - November 23, 2024
Johnson & Johnson MedTech Receives IDE Approval for OTTAVA Robotic Surgical System
November 13, 2024
NEW BRUNSWICK, New Jersey, Nov. 13 -- Johnson and Johnson issued the following news release on Nov. 12, 2024:

* * *

Company prepares to support clinical trial in the United States

* * *

Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery and vision solutions, today announced that the U.S. Food & Drug Administration (FDA) has approved the OTTAVA robotic surgical system investigational device exemption (IDE) . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products